INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 177 filers reported holding INTRA CELLULAR THERAPIES INC in Q3 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,180,283 | -24.4% | 137,841 | -8.1% | 0.01% | -23.5% |
| Q2 2023 | $9,500,638 | +14.5% | 150,042 | -2.1% | 0.02% | +13.3% |
| Q1 2023 | $8,298,882 | +13.7% | 153,258 | +11.1% | 0.02% | -6.2% |
| Q4 2022 | $7,297,851 | +5.9% | 137,903 | -6.9% | 0.02% | +6.7% |
| Q3 2022 | $6,889,000 | -23.7% | 148,046 | -6.4% | 0.02% | -25.0% |
| Q2 2022 | $9,033,000 | -22.0% | 158,247 | -16.2% | 0.02% | -13.0% |
| Q1 2022 | $11,576,000 | +33.3% | 188,920 | +14.0% | 0.02% | +43.8% |
| Q4 2021 | $8,683,000 | +54.1% | 165,649 | +9.5% | 0.02% | +33.3% |
| Q3 2021 | $5,636,000 | +199.0% | 151,324 | +227.5% | 0.01% | +200.0% |
| Q2 2021 | $1,885,000 | +217.9% | 46,209 | +164.5% | 0.00% | +300.0% |
| Q1 2021 | $593,000 | +37.3% | 17,471 | +28.5% | 0.00% | 0.0% |
| Q4 2020 | $432,000 | -36.6% | 13,598 | -48.8% | 0.00% | -50.0% |
| Q3 2020 | $681,000 | +134.0% | 26,533 | +134.3% | 0.00% | +100.0% |
| Q2 2020 | $291,000 | +66.3% | 11,322 | -0.6% | 0.00% | 0.0% |
| Q1 2020 | $175,000 | +503.4% | 11,385 | +375.2% | 0.00% | – |
| Q1 2019 | $29,000 | -44.2% | 2,396 | 0.0% | 0.00% | – |
| Q4 2018 | $52,000 | 0.0% | 2,396 | 0.0% | 0.00% | – |
| Q3 2018 | $52,000 | +23.8% | 2,396 | 0.0% | 0.00% | – |
| Q2 2018 | $42,000 | -97.5% | 2,396 | -97.9% | 0.00% | -100.0% |
| Q4 2016 | $1,690,000 | -2.3% | 112,000 | -1.4% | 0.01% | -11.1% |
| Q3 2016 | $1,730,000 | -60.1% | 113,548 | +1.7% | 0.01% | -65.4% |
| Q2 2016 | $4,333,000 | +54.6% | 111,612 | +10.7% | 0.03% | +52.9% |
| Q1 2016 | $2,803,000 | -38.2% | 100,814 | +19.5% | 0.02% | -39.3% |
| Q4 2015 | $4,539,000 | – | 84,389 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $42,833,000 | 8.57% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 308,819 | $18,897,000 | 7.82% |
| Vahanian & Associates Financial Planning Inc. | 45,533 | $2,786,000 | 6.44% |
| DCF Advisers, LLC | 238,500 | $14,594,000 | 6.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 50,956 | $20,930,000 | 4.72% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,531,923 | $93,738,000 | 2.86% |
| Nicholas Investment Partners, LP | 562,373 | $34,412,000 | 2.45% |
| Bellevue Group AG | 3,429,619 | $209,859,000 | 2.44% |
| WASATCH ADVISORS LP | 7,477,868 | $457,571,000 | 2.25% |
| Quantum Private Wealth, LLC | 73,772 | $4,514,000 | 1.95% |